•
NV
NVCT
Nuvectis Pharma, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
219.78M
Volume
57.22K
52W High
$11.52
52W Low
$5.55
Open
$0.00
Prev Close
$8.11
Day Range
0.00 - 0.00
About Nuvectis Pharma, Inc. Common Stock
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Latest News
Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock
GlobeNewswire Inc.•Feb 5
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
GlobeNewswire Inc.•Nov 5
Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
GlobeNewswire Inc.•Aug 29
Wall Street Analysts See a 229.34% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
Zacks Investment Research•May 24
Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference
GlobeNewswire Inc.•May 16
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire Inc.•May 7
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
GlobeNewswire Inc.•Apr 8
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
GlobeNewswire Inc.•Mar 19